FABP3 as Biomarker of Heart Pathology-Reference-Cited by-同舟云学术

FABP3 as Biomarker of Heart Pathology

Published:2014 Issue: Volume: Page:1-13
ISSN:
Container-title:General Methods in Biomarker Research and their Applications
language:
Short-container-title:

Author:

Catalucci Daniele,Latronico Michael V. G.,Condorelli Gianluigi

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-94-007-7740-8_22-1

Reference70 articles.

1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116:e148–304.

2. Appasani K. MicroRNAs: from basic science to disease biology. In: Appasani K, editor. MicroRNAs: from basic science to disease biology, vol. 1. London: Cambridge University Press; 2009. p. 1–3.

3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.

4. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 1999;13:805–12.

5. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213–23.